A carregar...
Vaccination in patients with inflammatory bowel diseases
During the course of disease, a majority of IBD patients requires long-term immunosuppressive therapy with either immunomodulatory agents, biologics or newer immunosuppressive therapies such as Vedolizumab, a selective α4β7 inhibitor, Ustekinumab, an IL 12/23 p40 inhibitor or the Janus kinase (JAK)...
Na minha lista:
| Publicado no: | Digestion |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7725278/ https://ncbi.nlm.nih.gov/pubmed/31968344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503253 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|